Cumberland Pharmaceuticals PE Ratio 2012-2025 | CPIX

Current and historical p/e ratio for Cumberland Pharmaceuticals (CPIX) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cumberland Pharmaceuticals PE ratio as of January 23, 2026 is 49.13.
Cumberland Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-01-23 3.93 0.00
2025-09-30 3.12 $-0.24 0.00
2025-06-30 3.35 $-0.22 0.00
2025-03-31 4.23 $-0.25 0.00
2024-12-31 2.37 $-0.47 0.00
2024-09-30 1.28 $-0.77 0.00
2024-06-30 1.53 $-0.73 0.00
2024-03-31 1.68 $-0.59 0.00
2023-12-31 1.79 $-0.44 0.00
2023-09-30 1.89 $-0.17 0.00
2023-06-30 1.47 $-0.13 0.00
2023-03-31 1.95 $-0.28 0.00
2022-12-31 2.25 $-0.38 0.00
2022-09-30 2.41 $-0.47 0.00
2022-06-30 2.08 $-0.51 0.00
2022-03-31 2.82 $-0.34 0.00
2021-12-31 4.67 $-0.24 0.00
2021-09-30 2.68 $-0.04 0.00
2021-06-30 2.85 0 0.00
2021-03-31 3.03 $-0.14 0.00
2020-12-31 2.95 $-0.22 0.00
2020-09-30 3.21 $-0.22 0.00
2020-06-30 3.33 $-0.32 0.00
2020-03-31 3.63 $-0.30 0.00
2019-12-31 5.15 $-0.23 0.00
2019-09-30 5.93 $-0.31 0.00
2019-06-30 6.37 $-0.29 0.00
2019-03-31 5.81 $-0.30 0.00
2018-12-31 6.03 $-0.45 0.00
2018-09-30 5.71 $-0.36 0.00
2018-06-30 6.13 $-0.30 0.00
2018-03-31 6.68 $-0.57 0.00
2017-12-31 7.36 $-0.50 0.00
2017-09-30 7.06 $-0.50 0.00
2017-06-30 7.00 $-0.44 0.00
2017-03-31 6.94 $-0.12 0.00
2016-12-31 5.50 $-0.06 0.00
2016-09-30 5.01 0 0.00
2016-06-30 4.50 0 0.00
2016-03-31 4.49 $0.02 224.50
2015-12-31 5.26 $0.04 131.50
2015-09-30 5.77 $0.07 82.43
2015-06-30 7.15 $0.10 71.50
2015-03-31 6.66 $0.12 55.50
2014-12-31 5.98 $0.14 42.71
2014-09-30 4.94 $0.02 247.00
2014-06-30 4.50 $-0.06 0.00
2014-03-31 4.50 $-0.13 0.00
2013-12-31 5.11 $-0.10 0.00
2013-09-30 4.53 $0.07 64.71
2013-06-30 5.11 $0.21 24.33
2013-03-31 4.98 $0.33 15.09
2012-12-31 4.20 $0.30 14.00
2012-09-30 6.46 $0.26 24.85
2012-06-30 6.46 $0.25 25.84
2012-03-31 7.50 $0.27 27.78
2011-12-31 5.38 $0.28 19.21
2011-09-30 5.58 $0.27 20.67
2011-06-30 5.75 $0.23 25.00
2011-03-31 5.53 $0.13 42.54
2010-12-31 5.99 $0.12 49.92
2010-09-30 5.81 $0.09 64.56
2010-06-30 6.42 $0.11 58.36
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.059B $0.038B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $91.260B 34.66
Zoetis (ZTS) United States $54.668B 19.57
Takeda Pharmaceutical (TAK) Japan $51.834B 10.58
Daiichi Sankyo, - (DSNKY) Japan $37.584B 18.72
BeOne Medicines - (ONC) Switzerland $37.211B 197.28
Sandoz Group AG (SDZNY) Switzerland $35.741B 0.00
United Therapeutics (UTHR) United States $20.191B 17.77
Merck (MKKGY) Germany $19.464B 12.00
Shionogi (SGIOY) Japan $16.929B 15.55
IPSEN (IPSEY) France $13.608B 0.00
Neurocrine Biosciences (NBIX) United States $13.578B 32.58
Ionis Pharmaceuticals (IONS) United States $13.004B 0.00
Summit Therapeutics (SMMT) United States $12.716B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.912B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.411B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.967B 21.19
Stevanato Group S.p.A (STVN) Italy $5.230B 29.27
Crinetics Pharmaceuticals (CRNX) United States $5.046B 0.00
Corcept Therapeutics (CORT) United States $4.626B 49.98
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.547B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.209B 19.99
Indivior (INDV) United States $4.122B 16.82
NewAmsterdam Pharma (NAMS) Netherlands $3.778B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.397B 0.00
Hypermarcas (HYPMY) Brazil $2.977B 20.43
Catalyst Pharmaceuticals (CPRX) United States $2.898B 9.25
Dyne Therapeutics (DYN) United States $2.571B 0.00
Soleno Therapeutics (SLNO) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.188B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Guardian Pharmacy Services (GRDN) United States $1.932B 37.21
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.916B 22.70
Ardelyx (ARDX) United States $1.888B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.731B 0.00
Oruka Therapeutics (ORKA) United States $1.665B 0.00
Harrow (HROW) United States $1.647B 101.07
Enliven Therapeutics (ELVN) United States $1.530B 0.00
Collegium Pharmaceutical (COLL) United States $1.438B 7.12
BioCryst Pharmaceuticals (BCRX) United States $1.431B 84.88
Relay Therapeutics (RLAY) United States $1.288B 0.00
Evotec AG (EVO) Germany $1.282B 0.00
Xeris Biopharma Holdings (XERS) United States $1.234B 0.00
Savara (SVRA) United States $1.225B 0.00
Aktis Oncology (AKTS) United States $1.097B 0.00
Cronos Group (CRON) Canada $1.061B 0.00
Theravance Biopharma (TBPH) United States $1.026B 43.06
ARS Pharmaceuticals (SPRY) United States $1.009B 0.00
Xencor (XNCR) United States $0.913B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.851B 20.12
KalVista Pharmaceuticals (KALV) United States $0.810B 0.00
Nektar Therapeutics (NKTR) United States $0.755B 0.00
Esperion Therapeutics (ESPR) United States $0.751B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.671B 5.99
Bioventus (BVS) United States $0.664B 13.59
ProKidney (PROK) United States $0.653B 0.00
Altimmune (ALT) United States $0.574B 0.00
Lexeo Therapeutics (LXEO) United States $0.547B 0.00
Lyell Immunopharma (LYEL) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.505B 0.00
Organogenesis (ORGO) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.488B 0.00
Elite Pharmaceuticals (ELTP) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.476B 6.51
4D Molecular Therapeutics (FDMT) United States $0.455B 0.00
Nature's Sunshine Products (NATR) United States $0.432B 25.70
USANA Health Sciences (USNA) United States $0.412B 11.49
Aquestive Therapeutics (AQST) United States $0.395B 0.00
Cybin (HELP) Canada $0.376B 0.00
Akebia Therapeutics (AKBA) United States $0.361B 0.00
Protara Therapeutics (TARA) United States $0.320B 0.00
Aldeyra Therapeutics (ALDX) United States $0.312B 0.00
Larimar Therapeutics (LRMR) United States $0.305B 0.00
Achieve Life Sciences (ACHV) Canada $0.298B 0.00
Avalo Therapeutics (AVTX) United States $0.292B 0.00
Profound Medical (PROF) Canada $0.289B 0.00
Fractyl Health (GUTS) United States $0.286B 0.00
Relmada Therapeutics (RLMD) United States $0.286B 0.00
OmniAb (OABI) United States $0.282B 0.00
Silence Therapeutics (SLN) United Kingdom $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.260B 0.00
Enlivex Therapeutics (ENLV) Israel $0.256B 0.00
Journey Medical (DERM) United States $0.236B 0.00
MediWound (MDWD) Israel $0.227B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.223B 0.00
Galectin Therapeutics (GALT) United States $0.213B 0.00
Century Therapeutics (IPSC) United States $0.212B 0.00
AleAnna (ANNA) United States $0.192B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Minerva Neurosciences (NERV) United States $0.172B 0.00
Surrozen (SRZN) United States $0.168B 0.00
Context Therapeutics (CNTX) United States $0.166B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
VAXART, INC (VXRT) United States $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.153B 0.00
Unicycive Therapeutics (UNCY) United States $0.149B 0.00
Avita Medical (RCEL) United States $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.131B 0.00
Prelude Therapeutics (PRLD) United States $0.127B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
Incannex Healthcare (IXHL) Australia $0.119B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.119B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
Korro Bio (KRRO) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 39.71
Gain Therapeutics (GANX) United States $0.079B 0.00
PolyPid (PYPD) Israel $0.076B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
NRx Pharmaceuticals (NRXP) United States $0.064B 0.00
Metagenomi Therapeutics (MGX) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Arch Biopartners (ACHFF) Canada $0.061B 0.00
Lipocine (LPCN) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.060B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Lite Strategy (LITS) United States $0.047B 0.00
Talphera (TLPH) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Wellgistics Health (WGRX) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
TherapeuticsMD (TXMD) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Klotho Neurosciences (KLTO) United States $0.024B 0.00
Liminatus Pharma (LIMN) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Traws Pharma (TRAW) United States $0.019B 0.02
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Inotiv (NOTV) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Vyome Holdings (HIND) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Tempest Therapeutics (TPST) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Nuvilex (PMCB) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00